Literature DB >> 11169537

Kinetics of finite dose absorption through skin 1. Vanillylnonanamide.

G B Kasting1.   

Abstract

Despite the considerable success in predicting the steady-state dermal absorption rates of chemical compounds from large reservoirs applied to skin, correspondingly little progress has been made in predicting the absorption rate and extent for small doses of topically applied compounds. In the latter case, steady-state absorption rates are generally not obtained, and rapid evaporation or penetration of the dose solvent makes application of permeability coefficient models problematic. This report presents a new analysis of the finite dose problem in terms of a diffusion model with three parameters-a characteristic time for diffusion, h2/D; a skin solubility factor, S(m)h; and a capacity factor for absorption of the dose during the dry down period, M*. These parameters can be related to the molecular weight and oil and water solubilities of the permeant in a manner similar to models describing steady-state absorption from saturated solutions. Some variation of the parameter values based on the chemical nature and volume of the dose solvent is anticipated. The applicability of the model is demonstrated by analyzing the in vitro absorption rates of varying doses of vanillylnonamide (VN, synthetic capsaicin) applied to excised human skin from propylene glycol. The analysis shows that a three-parameter model that assigns all of the resistance to transport to diffusion through the stratum corneum is able to explain most of the significant features of VN absorption through skin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169537     DOI: 10.1002/1520-6017(200102)90:2<202::aid-jps11>3.0.co;2-e

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Data-based modeling of drug penetration relates human skin barrier function to the interplay of diffusivity and free-energy profiles.

Authors:  Robert Schulz; Kenji Yamamoto; André Klossek; Roman Flesch; Stefan Hönzke; Fiorenza Rancan; Annika Vogt; Ulrike Blume-Peytavi; Sarah Hedtrich; Monika Schäfer-Korting; Eckart Rühl; Roland R Netz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

2.  Modeling of Drug Diffusion Based on Concentration Profiles in Healthy and Damaged Human Skin.

Authors:  Robert Schulz; Kenji Yamamoto; André Klossek; Fiorenza Rancan; Annika Vogt; Christof Schütte; Eckart Rühl; Roland R Netz
Journal:  Biophys J       Date:  2019-07-24       Impact factor: 4.033

3.  The transient dermal exposure II: post-exposure absorption and evaporation of volatile compounds.

Authors:  H Frederick Frasch; Annette L Bunge
Journal:  J Pharm Sci       Date:  2015-01-21       Impact factor: 3.534

4.  In Silico Modelling of Transdermal and Systemic Kinetics of Topically Applied Solutes: Model Development and Initial Validation for Transdermal Nicotine.

Authors:  Tao Chen; Guoping Lian; Panayiotis Kattou
Journal:  Pharm Res       Date:  2016-03-08       Impact factor: 4.200

5.  Development of a Two-Dimensional Model for Predicting Transdermal Permeation with the Follicular Pathway: Demonstration with a Caffeine Study.

Authors:  Panayiotis Kattou; Guoping Lian; Stephen Glavin; Ian Sorrell; Tao Chen
Journal:  Pharm Res       Date:  2017-06-28       Impact factor: 4.200

6.  Assessment of Vehicle Volatility and Deposition Layer Thickness in Skin Penetration Models.

Authors:  Abdullah Hamadeh; John Troutman; Andrea N Edginton
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

7.  Analysis of finite dose dermal absorption data: implications for dermal exposure assessment.

Authors:  H Frederick Frasch; G Scott Dotson; Annette L Bunge; Chen-Peng Chen; John W Cherrie; Gerald B Kasting; John C Kissel; Jennifer Sahmel; Sean Semple; Simon Wilkinson
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-05-29       Impact factor: 5.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.